Digital Currency X Technology raised approximately $5.0 million by selling 23,809,530 ordinary shares with matching Series A and Series B warrants. The proceeds are intended for working capital, corporate purposes, digital-asset operations and directors’ and officers’ insurance, giving investors a defined view of the capital’s planned uses.

Key Highlights

  • The securities were sold at US$0.21 per ordinary share alongside the two Warrant classes.
  • The offering included Series A warrants and Series B warrants linked to the same aggregate number of underlying securities as the ordinary shares.
  • Directors, officers and shareholders holding 5% agreed to a 90-day lock-up, subject to specified exceptions.

Digital Currency X Technology Inc. (NASDAQ: DCX) raised approximately US$5.0 million through a registered direct offering that closed on September 21, 2026. The transaction involved 23,809,530 ordinary shares, plus Series A warrants and Series B warrants linked to the same aggregate number of underlying securities. The capital is intended for working capital, general corporate purposes, digital-asset activities and directors’ and officers’ insurance. The purchase price was US$0.21 for each ordinary share and its accompanying warrant package. The company received an aggregate purchase price of US$5,000,001.30 at closing.

Share And Warrant Package

The offering combined ordinary shares with two separate warrant instruments. The securities and their exercise prices may be adjusted for events including share dividends, splits, combinations, reclassifications, share-combination VWAP resets and subsequent dilutive issuances. The offering was made under the company’s registration statement, base prospectus and prospectus supplement.

Proceeds And Transaction Costs

Digital Currency X Technology plans to direct the net proceeds toward Working Capital and general corporate purposes. The stated uses may include acquiring, holding, safeguarding, staking, managing and disposing of digital Assets and cryptocurrencies, along with related treasury and Business operations. The stated intended uses form part of the company’s forward-looking statements regarding execution of its business strategy.

Lock-Up And Issuance Limits

Subject to specified exceptions, those agreements restrict offers, sales, pledges and other dispositions of covered ordinary shares and related securities for 90 days after the closing date. The purchase agreement also restricts the company and its subsidiaries, subject to exceptions, from issuing or agreeing to issue ordinary shares or securities tied to ordinary shares during the defined period beginning September 18, 2026. The agreement includes customary representations, warranties, closing conditions and indemnification obligations.